These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7655150)
1. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests. Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study. Lizard G; Roignot P; Maynadie M; Lizard-Nacol S; Poupon MF; Bordes M Cancer Detect Prev; 1995; 19(6):527-34. PubMed ID: 8925522 [TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines. Maynadie M; Lizard G; Solary E; Roignot P; Carli PM Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688 [TBL] [Abstract][Full Text] [Related]
5. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies. Van Acker KL; Van Hove LM; Boogaerts MA Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231 [TBL] [Abstract][Full Text] [Related]
7. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Schuurhuis GJ; Broxterman HJ; Ossenkoppele GJ; Baak JP; Eekman CA; Kuiper CM; Feller N; van Heijningen TH; Klumper E; Pieters R Clin Cancer Res; 1995 Jan; 1(1):81-93. PubMed ID: 9815890 [TBL] [Abstract][Full Text] [Related]
8. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome. Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636 [TBL] [Abstract][Full Text] [Related]
9. Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart. Rosati A; Decorti G; Klugmann FB; Candussio L; Granzotto M; Melato M; Giraldi T Anticancer Res; 2000; 20(5B):3403-10. PubMed ID: 11131640 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia. Del Poeta G; Stasi R; Aronica G; Venditti A; Cox MC; Bruno A; Buccisano F; Masi M; Tribalto M; Amadori S; Papa G Blood; 1996 Mar; 87(5):1997-2004. PubMed ID: 8634450 [TBL] [Abstract][Full Text] [Related]
11. Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris. Marie JP; Huet S; Faussat AM; Perrot JY; Chevillard S; Barbu V; Bayle C; Boutonnat J; Calvo F; Campos-Guyotat L; Colosetti P; Cazin JL; de Cremoux P; Delvincourt C; Demur C; Drenou B; Fenneteau O; Feuillard J; Garnier-Suillerot A; Genne P; Gorisse MC; Gosselin P; Jouault H; Lacave R; Robert J Leukemia; 1997 Jul; 11(7):1086-94. PubMed ID: 9204996 [TBL] [Abstract][Full Text] [Related]
12. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123 [TBL] [Abstract][Full Text] [Related]
14. Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate. Eytan GD; Regev R; Oren G; Hurwitz CD; Assaraf YG Eur J Biochem; 1997 Aug; 248(1):104-12. PubMed ID: 9310367 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. van der Pol JP; Blom DJ; Flens MJ; Luyten GP; de Waard-Siebinga I; Koornneef L; Scheper RJ; Jager MJ Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2523-30. PubMed ID: 9375571 [TBL] [Abstract][Full Text] [Related]
16. Flow cytometric double labeling technique for screening of multidrug resistance. Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985 [TBL] [Abstract][Full Text] [Related]
17. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related]
18. Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples. Canitrot Y; Lahmy S; Buquen JJ; Canitrot D; Lautier D Cancer Lett; 1996 Aug; 106(1):59-68. PubMed ID: 8827047 [TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells]. Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264 [TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]